Bone marrow stromal cells reduce ischemia-induced astrocytic activation in vitro

Neuroscience

Volumn 152, Issue 3, 2008, Pages 646-655

  Gao, Q ^a   Li, Y ^a   Shen, L ^a   Zhang, J ^a   Zheng, X ^a   Qu, R ^a   Liu, Z ^a   Chopp, M ^a,b  

^a HENRY FORD HOSPITAL   (United States)

^b OAKLAND UNIVERSITY   (United States)

Author keywords

astrocyte; bone marrow stromal cell; gp130; IL 6; IL 6 receptor; stroke

Indexed keywords

GLIAL FIBRILLARY ACIDIC PROTEIN; GLUCOSE; GLYCOPROTEIN GP 130; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR ALPHA; OXYGEN; SMALL INTERFERING RNA;

ANIMAL CELL; ARTICLE; ASTROCYTE; ASTROCYTOSIS; BONE MARROW CELL; CELL ACTIVATION; CELL INTERACTION; CELL PROLIFERATION; CELL PROTECTION; CELL STRUCTURE; CENTRAL NERVOUS SYSTEM DISEASE; CONTROLLED STUDY; DOWN REGULATION; IN VITRO STUDY; ISCHEMIA; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REOXYGENATION; STROMA CELL;

ANIMALS; ASTROCYTES; BONE MARROW CELLS; BRAIN ISCHEMIA; CELL COMMUNICATION; CELL PROLIFERATION; CELLS, CULTURED; COCULTURE TECHNIQUES; CYTOKINE RECEPTOR GP130; CYTOPROTECTION; DOWN-REGULATION; GLIAL FIBRILLARY ACIDIC PROTEIN; GLIOSIS; GRAFT SURVIVAL; INTERLEUKIN-6; MICE; RECEPTORS, INTERLEUKIN-6; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; STROMAL CELLS;

EID: 41049102868     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2007.10.069     Document Type: Article

References (43)

1. Acalovschi D., Wiest T., Hartmann M., Farahmi M., Mansmann U., Auffarth G.U., Grau A.J., Green F.R., Grond-Ginsbach C., and Schwaninger M. Multiple levels of regulation of the interleukin-6 system in stroke. Stroke 34 (2003) 1864-1869
2. Chen J., Li Y., Wang L., Zhang Z.G., Lu D., Lu M., and Chopp M. Therapeutic benefit of intravenous administration of bone marrow stromal cells after cerebral ischemia in rats. Stroke 32 (2001) 1005-1011
3. Chen J., Li Y., Wang L., Lu M., Zhang X., and Chopp M. Therapeutic benefit of intracerebral transplantation of bone marrow-derived MSCs after cerebral ischemia in rats. J Neurol Sci 189 (2001) 49-57
4. Chopp M., and Li Y. Transplantation of bone marrow stromal cells for treatment of central nervous system diseases. Adv Exp Med Biol 585 (2006) 49-64
5. Dietrich P.Y., Walker P.R., and Saas P. Death receptors on reactive astrocytes: a key role in the fine tuning of brain inflammation?. Neurology 60 (2003) 548-554
6. Fattori E., Lazzaro D., Musiani P., Modesti A., Alonzi T., and Ciliberto G. IL-6 expression in neurons of transgenic mice causes reactive astrocytosis and increase in ramified microglial cells but no neuronal damage. Eur J Neurosci 7 (1995) 2441-2449
7. Friedenstein A.J., Gorskaja J.F., and Kulagina N.N. Fibroblast precursors in normal and irradiated mouse hematopoietic organs. Exp Hematol 4 (1976) 267-274
8. Gadient R.A., and Otten U.H. Interleukin-6 (IL-6): a molecule with both beneficial and destructive potentials. Prog Neurobiol 52 (1997) 379-390
9. Gao Q., Katakowski M., Chen X., Li Y., and Chopp M. Human marrow stromal cells enhance connexin43 gap junction intercellular communication in cultured astrocytes. Cell Transplant 14 (2005) 109-117
10. Gao Q., Li Y., and Chopp M. Bone marrow stromal cells increase astrocyte survival via up-regulation of phosphoinositide 3-kinase/threonine protein kinase and mitogen-activated protein kinase kinase/extracellular signal-regulated kinase pathways and stimulate astrocyte trophic factor gene expression after anaerobic insult. Neuroscience 136 (2005) 123-134
11. Goldshmit Y., Galea M.P., Wise G., Bartlett P.F., and Turnley A.M. Axonal regeneration and lack of astrocytic gliosis in EphA4-deficient mice. J Neurosci 24 (2004) 10064-10073
12. Gruol D.L., and Nelson T.E. Physiological and pathological roles of interleukin-6 in the central nervous system. Mol Neurobiol 15 (1997) 307-339
13. Hess D.C., Hill W.D., Martin-Studdard A., Carroll J., Brailer J., and Carothers J. Bone marrow as a source of endothelial cells and NeuN-expressing cells after stroke. Stroke 33 (2002) 1362-1368
14. Hori O., Matsumoto M., Kuwabara K., Maeda Y., Ueda H., Ohtsuki T., Kinoshita T., Ogawa S., Stern D.M., and Kamada T. Exposure of astrocytes to hypoxia/reoxygenation enhances expression of glucose-regulated protein 78 facilitating astrocyte release of the neuroprotective cytokine interleukin 6. J Neurochem 66 (1996) 973-979
15. Jones S.A., Richards P.J., Scheller J., and Rose-John S. IL-6 transsignaling: the in vivo consequences. J Interferon Cytokine Res 25 (2005) 241-253
16. Li Y., Chen J., Chen X.G., Wang L., Gautam S.C., Xu Y.X., Katakowski M., Zhang L.J., Lu M., Janakiraman N., and Chopp M. Human marrow stromal cell therapy for stroke in rat: Neurotrophins and functional recovery. Neurology 59 (2002) 514-523
17. Li Y., Chen J., Zhang C.L., Wang L., Lu D., Katakowski M., Gao Q., Shen L.H., Zhang J., Lu M., and Chopp M. Gliosis and brain remodeling after treatment of stroke in rats with marrow stromal cells. Glia 49 (2005) 407-417
18. Lu M., Chen J., Lu D., Yi L., Mahmood A., and Chopp M. Global test statistics for treatment effect of stroke and trauma brain injury in rats with administration of bone marrow stromal cells. J Neurosci Methods 128 (2003) 183-190
19. Maeda Y., Matsumoto M., Hori O., Kuwabara K., Ogawa S., Yan S.D., Ohtsuki T., Kinoshita T., Kamada T., and Stern D.M. Hypoxia/reoxygenation-mediated induction of astrocyte interleukin 6: a paracrine mechanism potentially enhancing neuron survival. J Exp Med 180 (1994) 2297-2308
20. Marz P., Heese K., Dimitriades-Schmutz B., Rose-John S., and Otten U. Role of interleukin-6 and soluble IL-6 receptor in region-specific induction of astrocytic differentiation and neurotrophin expression. Glia 26 (1999) 191-200
21. Menet V., Gimenez y Ribotta M., Chauvet N., Drian M.J., Lannoy J., Colucci-Guyon E., and Privat A. Inactivation of the glial fibrillary acidic protein gene, but not that of vimentin, improves neuronal survival and neurite growth by modifying adhesion molecule expression. J Neurosci 21 (2001) 6147-6158
22. Menet V., Gimenez Y.R.M., Sandillon F., and Privat A. GFAP null astrocytes are a favorable substrate for neuronal survival and neurite growth. Glia 31 (2000) 267-272
23. Menet V., Prieto M., Privat A., and Gimenez y Ribotta M. Axonal plasticity and functional recovery after spinal cord injury in mice deficient in both glial fibrillary acidic protein and vimentin genes. Proc Natl Acad Sci U S A 100 (2003) 8999-9004
24. Mullberg J., Althoff K., Jostock T., and Rose-John S. The importance of shedding of membrane proteins for cytokine biology. Eur Cytokine Netw 11 (2000) 27-38
25. Oh J.W., Van Wagoner N.J., Rose-John S., and Benveniste E.N. Role of IL-6 and the soluble IL-6 receptor in inhibition of VCAM-1 gene expression. J Immunol 161 (1998) 4992-4999
26. Pekny M., Johansson C.B., Eliasson C., Stakeberg J., Wallen A., Perlmann T., Lendahl U., Betsholtz C., Berthold C.H., and Frisen J. Abnormal reaction to central nervous system injury in mice lacking glial fibrillary acidic protein and vimentin. J Cell Biol 145 (1999) 503-514
27. Pekny M., and Pekna M. Astrocyte intermediate filaments in CNS pathologies and regeneration. J Pathol 204 (2004) 428-437
28. Peters M., Muller A.M., and Rose-John S. Interleukin-6 and soluble interleukin-6 receptor: direct stimulation of gp130 and hematopoiesis. Blood 92 (1998) 3495-3504
29. Rempe D.A., and Kent T.A. Using bone marrow stromal cells for treatment of stroke. Neurology 59 (2002) 486-487
30. Rose-John S. Coordination of interleukin-6 biology by membrane bound and soluble receptors. Adv Exp Med Biol 495 (2001) 145-151
31. Rose-John S., and Heinrich P.C. Soluble receptors for cytokines and growth factors: generation and biological function. Biochem J 300 Pt 2 (1994) 281-290
32. Shen L.H., Li Y., Chen J., Zacharek A., Gao Q., Kapke A., Lu M., Raginski K., Vanguri P., Smith A., and Chopp M. Therapeutic benefit of bone marrow stromal cells administered 1 month after stroke. J Cereb Blood Flow Metab 27 (2006) 6-13
33. Silver J., and Miller J.H. Regeneration beyond the glial scar. Nat Rev Neurosci 5 (2004) 146-156
34. Smith Q.R. A review of blood-brain barrier transport techniques. Methods Mol Med 89 (2003) 193-208
35. Song S., Kamath S., Mosquera D., Zigova T., Sanberg P., Vesely D.L., and Sanchez-Ramos J. Expression of brain natriuretic peptide by human bone marrow stromal cells. Exp Neurol 185 (2004) 191-197
36. Tacconi M.T. Neuronal death: is there a role for astrocytes?. Neurochem Res 23 (1998) 759-765
37. Taga T., and Kishimoto T. Gp130 and the interleukin-6 family of cytokines. Annu Rev Immunol 15 (1997) 797-819
38. Tilgner J., Volk B., and Kaltschmidt C. Continuous interleukin-6 application in vivo via macroencapsulation of interleukin-6-expressing COS-7 cells induces massive gliosis. Glia 35 (2001) 234-245
39. Van Wagoner N.J., and Benveniste E.N. Interleukin-6 expression and regulation in astrocytes. J Neuroimmunol 100 (1999) 124-139
40. Van Wagoner N.J., Oh J.W., Repovic P., and Benveniste E.N. Interleukin-6 (IL-6) production by astrocytes: autocrine regulation by IL-6 and the soluble IL-6 receptor. J Neurosci 19 (1999) 5236-5244
41. Waje-Andreassen U., Krakenes J., Ulvestad E., Thomassen L., Myhr K.M., Aarseth J., and Vedeler C.A. IL-6: an early marker for outcome in acute ischemic stroke. Acta Neurol Scand 111 (2005) 360-365
42. Wilhelmsson U., Li L., Pekna M., Berthold C.H., Blom S., Eliasson C., Renner O., Bushong E., Ellisman M., Morgan T.E., and Pekny M. Absence of glial fibrillary acidic protein and vimentin prevents hypertrophy of astrocytic processes and improves post-traumatic regeneration. J Neurosci 24 (2004) 5016-5021
43. Wu V.W., and Schwartz J.P. Cell culture models for reactive gliosis: new perspectives. J Neurosci Res 51 (1998) 675-681